341 related articles for article (PubMed ID: 34090865)
1. Nanomedicine-based strategies to target and modulate the tumor microenvironment.
Mendes BB; Sousa DP; Conniot J; Conde J
Trends Cancer; 2021 Sep; 7(9):847-862. PubMed ID: 34090865
[TBL] [Abstract][Full Text] [Related]
2. ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.
Malla RR; Kamal MA
Curr Med Chem; 2021; 28(28):5674-5698. PubMed ID: 33297907
[TBL] [Abstract][Full Text] [Related]
3. Organoids technology for advancing the clinical translation of cancer nanomedicine.
Zhao DK; Liang J; Huang XY; Shen S; Wang J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
[TBL] [Abstract][Full Text] [Related]
4. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
Hu M; Huang L
Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
[TBL] [Abstract][Full Text] [Related]
5. Anticancer nanomedicines harnessing tumor microenvironmental components.
Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
[TBL] [Abstract][Full Text] [Related]
6. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology as a Delivery Tool for Precision Cancer Therapies.
Sharma B; Crist RM; Adiseshaiah PP
AAPS J; 2017 Nov; 19(6):1632-1642. PubMed ID: 29019032
[TBL] [Abstract][Full Text] [Related]
8. Role of intravital imaging in nanomedicine-assisted anti-cancer therapy.
Lu L; Sun Y; Wan C; Hu Y; Lo PC; Lovell JF; Yang K; Jin H
Curr Opin Biotechnol; 2021 Jun; 69():153-161. PubMed ID: 33476937
[TBL] [Abstract][Full Text] [Related]
9. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
10. Targeting Tumor Microenvironment for Cancer Therapy.
Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
[TBL] [Abstract][Full Text] [Related]
11. Tumor Abnormality-Oriented Nanomedicine Design.
Zhou Q; Xiang J; Qiu N; Wang Y; Piao Y; Shao S; Tang J; Zhou Z; Shen Y
Chem Rev; 2023 Sep; 123(18):10920-10989. PubMed ID: 37713432
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira MJ; Castro F; Oliveira MJ; Sarmento B
Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
[TBL] [Abstract][Full Text] [Related]
13. Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy.
Jha A; Kumar M; Bharti K; Manjit M; Mishra B
Nanomedicine (Lond); 2024 Mar; 19(7):633-651. PubMed ID: 38445583
[TBL] [Abstract][Full Text] [Related]
14. Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.
Wu M; Niu X; Zhang R; Ping Xu Z
Adv Drug Deliv Rev; 2022 Aug; 187():114360. PubMed ID: 35636568
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy.
Xu X; Wu Y; Qian X; Wang Y; Wang J; Li J; Li Y; Zhang Z
Adv Healthc Mater; 2022 Jan; 11(1):e2101428. PubMed ID: 34706400
[TBL] [Abstract][Full Text] [Related]
16. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
Tanaka HY; Kano MR
Cancer Sci; 2018 Jul; 109(7):2085-2092. PubMed ID: 29737600
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Incorporated Nanomedicines for Cancer Therapy.
Wu SY; Wu FG; Chen X
Adv Mater; 2022 Jun; 34(24):e2109210. PubMed ID: 35142395
[TBL] [Abstract][Full Text] [Related]
18. Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy.
Wang X; Li S; Liu X; Wu X; Ye N; Yang X; Li Z
Adv Exp Med Biol; 2021; 1295():77-95. PubMed ID: 33543456
[TBL] [Abstract][Full Text] [Related]
19. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.
Balasubramanian V; Liu Z; Hirvonen J; Santos HA
Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28570787
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
